Skip to main content
Premium Trial:

Request an Annual Quote

Counsyl Raises $80M

NEW YORK (GenomeWeb) – Genetic testing firm Counsyl reported today that it has raised $80 million in financing from life sciences investment firm Perceptive Advisors.

Counsyl Cofounder and CEO Ramji Srinivasan said in a statement that the new financing will be used to grow the company "with an eye toward making expanded carrier screening as routine as taking folic acid, noninvasive prenatal screening as routine as an ultrasound, and hereditary cancer screening as well-known as a pap smear."

The firm offers tests such as Foresight Carrier Screen, Prelude Prenatal Screen, and Reliant Cancer Screen. Since its founding, Counsyl has screened more than 850,000 patients, served more than 17,000 healthcare providers, and provided more than 60,000 genetic counseling sessions, it noted.

The company previously raised $28 million in 2014. According to Counsyl's website, the firm had previously raised a total of $102 million. 

The company also announced today that Home Care Assistance CEO Lily Sarafan has joined Counsyl's board.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.